Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of DPP4 Inhibition on Growth Hormone Secretion

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Vanderbilt University
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Jessica Koch Devin, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT01701973
First received: October 3, 2012
Last updated: April 29, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)